Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Link
http://link.springer.com/article/10.1007/s40265-018-0895-5/fulltext.html
Reference28 articles.
1. Soriano V, Benitez-Gutierrez L, Arias A, et al. Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C. Expert Opin Drug Metab Toxicol. 2017;13:1015–1022. https://doi.org/10.1080/17425255.2017.1359254 .
2. Carter W, Connelly S, Struble K. Reinventing HCV treatment: past and future perspectives. J Clin Pharmacol. 2017;57(3):287–96.
3. Gilead Sciences Inc. US prescribing information: Vosevi® (sofosbuvir, velpatasvir, and voxilaprevir) tablets. 2017. http://www.gilead.com/ . Accessed 28 Sept 2017.
4. European Medicines Agency. Vosevi 400 mg/100 mg/100 mg film-coated tablets: summary of product characteristics. 2017. http://www.ema.europa.eu/ema/ . Accessed 28 Sept 2017.
5. Greig SL. Sofosbuvir/velpatasvir: a review in chronic hepatitis C. Drugs. 2016;76(16):1567–78.
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antimicrobial and Antibiofilm Effects of Bithionol against Mycobacterium abscessus;Antibiotics;2024-06-05
2. Fluorine in the pharmaceutical industry: Synthetic approaches and application of clinically approved fluorine-enriched anti-infectious medications;European Journal of Medicinal Chemistry;2024-05
3. Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the treatment of chronic hepatitis C: the real-world data in China;BMC Gastroenterology;2024-02-14
4. An insight into the interaction of silicon decorated fullerene and single walled carbon nanotube towards umifenovir: DFT, QTAIM and molecular docking studies;Diamond and Related Materials;2023-12
5. Recent Methods for the Synthesis of Quinoxaline Derivatives and their Biological Activities;Mini-Reviews in Medicinal Chemistry;2023-10-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3